Unresectable Metastatic Colorectal Cancer
我们是谁
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
alloSHRINK - 使用基于 NKG2D 的 CYAD-101 嵌合抗原受体 T 细胞的异体 NKG2D 标准 cHemotherapy 方案和免疫疗法
转移性结直肠癌患者在 CYAD-101 治疗后使用 FOLFOX 预处理的 Pembrolizumab 治疗研究
